Insurance notes / check who pays
Take the product name and the reason it is being prescribed to your insurer. Ask what the plan needs before it can answer the cost question.
A formulary is the list of medicines your plan covers. With prior authorization, payment needs the plan’s approval before the prescription can be filled.
Medicare Part D is the Medicare prescription-drug benefit.
As of September 26, 2026, medicines prescribed for weight loss remain outside ordinary Medicare Part D coverage.
The reason for the prescription can change whether Part D may pay. It may cover medicine for type 2 diabetes, or heart attack or stroke risk reduction in adults with heart disease and overweight or obesity.
Certain weight medicines are available through a temporary program called the Medicare GLP-1 Bridge. GLP-1, a body hormone, plays a part in hunger and blood-sugar control. A copay is the patient’s share of an insured bill.
Medicare program terms
As of September 26, 2026, qualifying Part D members can get certain weight medicines for $50 per month through the Medicare GLP-1 Bridge.
The program starts on July 1, 2026, and ends on December 31, 2027. It pays separately from ordinary Part D drug coverage.
Ask the prescriber to check your age, weight, health problems, plan and medicine against the program’s rules. A prescription and approval before payment are required.
The weight-and-health rules below apply when treatment starts. You must be at least 18. BMI uses your height and weight to produce a number; ask the doctor to work out yours.
You may qualify with BMI 35 or higher; or BMI 30 or higher with certain health problems. Those problems are heart failure with a preserved heart squeeze, blood pressure above the program’s limit even with two medicines, or stage 3a or higher kidney disease.
BMI 27 or higher offers a third route if you have pre-diabetes, have had a heart attack or stroke, or have artery disease with limb symptoms.
As of September 26, 2026, people with type 2 diabetes must seek payment through ordinary Part D, rather than the Bridge. This is a different way to ask for help, not a promise that the plan will pay.
The Bridge also excludes moderate or severe obstructive sleep apnea, where blocked breathing interrupts sleep. It excludes MASH, a form of fatty liver disease, when scarring is moderate or advanced and cirrhosis is absent; cirrhosis means severe liver scarring. A prescription to lower major heart or stroke risks goes to the Part D plan too.
A GLP-1 medicine payment from Part D at any point in 2026 rules out Bridge use for that year. The doctor must also check that your plan qualifies and that the prescription includes an ongoing food and activity plan.
You really do pay the Bridge’s $50 each month. It neither lowers your Part D deductible nor counts toward the annual cap on your payments for covered Part D drugs.
The Bridge gives no extra discount for people with low incomes.
Ask whether the quote is for a savings card or a self-pay offer.
As of September 26, 2026, savings cards for semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) require workplace or private insurance. Those cards are unavailable to anyone covered by Medicare, Medicaid or military insurance.
Medicare or Medicaid members may still use a medicine maker’s separate cash offer. NovoCare allows those members to pay its cash price for Wegovy or Ozempic.
A cash payment outside insurance does not reduce your deductible, the amount you pay before some plan benefits begin. It does not count toward your out-of-pocket maximum, which caps your payments for covered care each year.
Keep going
Know the concerns to pause over